A multidrug resistance plasmid contains the molecular switch for type VI secretion in Acinetobacter baumannii

Proceedings of the National Academy of Sciences of the United States of America

Volumn 112, Issue 30, 2015, Pages 9442-9447

  Weber, Brent S ^a,b   Ly, Pek Man ^a   Irwin, Joshua N ^a   Pukatzki, Stefan ^a   Feldman, Mario F ^a,b  

^a UNIVERSITY OF ALBERTA   (Canada)

^b WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Acinetobacter baumannii; Antibiotic resistance; Bacterial secretion; Plasmid; T6SS

Indexed keywords

ANTIBIOTIC AGENT; ANTIINFECTIVE AGENT; BACTERIAL SECRETION SYSTEM; RECOMBINANT PROTEIN;

ACINETOBACTER BAUMANNII; ACINETOBACTER INFECTION; ANTIBIOTIC RESISTANCE; ANTIBIOTIC SENSITIVITY; ARTICLE; BACTERIAL STRAIN; CONTROLLED STUDY; CORRELATIONAL STUDY; GENE ACTIVATION; GENE LOSS; MULTIDRUG RESISTANCE; NONHUMAN; PHENOTYPE; PLASMID; PRIORITY JOURNAL; TYPE IV SECRETION SYSTEM; TYPE VI SECRETION SYSTEM; BACTERIAL SECRETION SYSTEM; CHEMISTRY; DNA SEQUENCE; ENZYME LINKED IMMUNOSORBENT ASSAY; ESCHERICHIA COLI; GENETICS; METABOLISM; MICROBIAL SENSITIVITY TEST; MOLECULAR GENETICS; NUCLEOTIDE SEQUENCE; SEQUENCE HOMOLOGY;

ACINETOBACTER BAUMANNII; BACTERIA (MICROORGANISMS); NEGIBACTERIA;

ACINETOBACTER BAUMANNII; ANTI-BACTERIAL AGENTS; BACTERIAL SECRETION SYSTEMS; BASE SEQUENCE; DRUG RESISTANCE, MULTIPLE, BACTERIAL; ENZYME-LINKED IMMUNOSORBENT ASSAY; ESCHERICHIA COLI; MICROBIAL SENSITIVITY TESTS; MOLECULAR SEQUENCE DATA; PHENOTYPE; PLASMIDS; RECOMBINANT PROTEINS; SEQUENCE ANALYSIS, DNA; SEQUENCE HOMOLOGY, NUCLEIC ACID;

EID: 84938149446     PISSN: 00278424     EISSN: 10916490     Source Type: Journal    
DOI: 10.1073/pnas.1502966112     Document Type: Article

References (48)

1. Boucher HW, et al. (2009) Bad bugs, no drugs: No ESKAPE! An update from the Infectious Diseases Society of America. Clin Infect Dis 48(1):1-12.
2. Sievert DM, et al.; National Healthcare Safety Network (NHSN) Team and Participating NHSN Facilities (2013) Antimicrobial-resistant pathogens associated with healthcareassociated infections: Summary of data reported to the National Healthcare Safety Network at the Centers for Disease Control and Prevention, 2009-2010. Infect Control Hosp Epidemiol 34(1):1-14.
3. Valencia R, et al. (2009) Nosocomial outbreak of infection with pan-drug-resistant Acinetobacter baumannii in a tertiary care university hospital. Infect Control Hosp Epidemiol 30(3):257-263.
4. Maragakis LL, Tucker MG, Miller RG, Carroll KC, Perl TM (2008) Incidence and prevalence of multidrug-resistant acinetobacter using targeted active surveillance cultures. JAMA 299(21):2513-2514.
5. Hibbing ME, Fuqua C, Parsek MR, Peterson SB (2010) Bacterial competition: Surviving and thriving in the microbial jungle. Nat Rev Microbiol 8(1):15-25.
6. Mougous JD, et al. (2006) A virulence locus of Pseudomonas aeruginosa encodes a protein secretion apparatus. Science 312(5779):1526-1530.
7. Pukatzki S, et al. (2006) Identification of a conserved bacterial protein secretion system in Vibrio cholerae using the Dictyostelium host model system. Proc Natl Acad Sci USA 103(5):1528-1533.
8. Boyer F, Fichant G, Berthod J, Vandenbrouck Y, Attree I (2009) Dissecting the bacterial type VI secretion system by a genome wide in silico analysis: What can be learned from available microbial genomic resources? BMC Genomics 10:104.
9. Hood RD, et al. (2010) A type VI secretion system of Pseudomonas aeruginosa targets a toxin to bacteria. Cell Host Microbe 7(1):25-37.
10. Basler M, Pilhofer M, Henderson GP, Jensen GJ, Mekalanos JJ (2012) Type VI secretion requires a dynamic contractile phage tail-like structure. Nature 483(7388):182-186.
11. Russell AB, et al. (2011) Type VI secretion delivers bacteriolytic effectors to target cells. Nature 475(7356):343-347.
12. Bingle LE, Bailey CM, Pallen MJ (2008) Type VI secretion: A beginner's guide. Curr Opin Microbiol 11(1):3-8.
13. Cascales E (2008) The type VI secretion toolkit. EMBO Rep 9(8):735-741.
14. Pukatzki S, McAuley SB, Miyata ST (2009) The type VI secretion system: Translocation of effectors and effector-domains. Curr Opin Microbiol 12(1):11-17.
15. Basler M, Mekalanos JJ (2012) Type 6 secretion dynamics within and between bacterial cells. Science 337(6096):815.
16. Basler M, Ho BT, Mekalanos JJ (2013) Tit-for-tat: Type VI secretion system counterattack during bacterial cell-cell interactions. Cell 152(4):884-894.
17. Ho BT, Basler M, Mekalanos JJ (2013) Type 6 secretion system-mediated immunity to type 4 secretion system-mediated gene transfer. Science 342(6155):250-253.
18. Bernard CS, Brunet YR, Gueguen E, Cascales E (2010) Nooks and crannies in type VI secretion regulation. J Bacteriol 192(15):3850-3860.
19. Silverman JM, Brunet YR, Cascales E, Mougous JD (2012) Structure and regulation of the type VI secretion system. Annu Rev Microbiol 66:453-472.
20. De Berardinis V, et al. (2008) A complete collection of single-gene deletion mutants of Acinetobacter baylyi ADP1. Mol Syst Biol 4:174.
21. Weber BS, et al. (2013) Genomic and functional analysis of the type VI secretion system in Acinetobacter. PLoS One 8(1):e55142.
22. Carruthers MD, Nicholson PA, Tracy EN, Munson RS, Jr (2013) Acinetobacter baumannii utilizes a type VI secretion system for bacterial competition. PLoS One 8(3):e59388.
23. Shneider MM, et al. (2013) PAAR-repeat proteins sharpen and diversify the type VI secretion system spike. Nature 500(7462):350-353.
24. Carruthers MD, et al. (2013) Draft genome sequence of the clinical isolate Acinetobacter nosocomialis strain M2. Genome Announc 1(6):e00906-13.
25. Henry R, et al. (2012) Colistin-resistant, lipopolysaccharide-deficient Acinetobacter baumannii responds to lipopolysaccharide loss through increased expression of genes involved in the synthesis and transport of lipoproteins, phospholipids, and poly-β-1, 6-N-acetylglucosamine. Antimicrob Agents Chemother 56(1):59-69.
26. Ahmed-Bentley J, et al. (2013) Gram-negative bacteria that produce carbapenemases causing death attributed to recent foreign hospitalization. Antimicrob Agents Chemother 57(7):3085-3091.
27. Miyata ST, Unterweger D, Rudko SP, Pukatzki S (2013) Dual expression profile of type VI secretion system immunity genes protects pandemic Vibrio cholerae. PLoS Pathog 9(12):e1003752.
28. Eid J, et al. (2009) Real-time DNA sequencing from single polymerase molecules. Science 323(5910):133-138.
29. Smith MG, et al. (2007) New insights into Acinetobacter baumannii pathogenesis revealed by high-density pyrosequencing and transposon mutagenesis. Genes Dev 21(5):601-614.
30. Fang FC, Rimsky S (2008) New insights into transcriptional regulation by H-NS. Curr Opin Microbiol 11(2):113-120.
31. Salomon D, Klimko JA, Orth K (2014) H-NS regulates the Vibrio parahaemolyticus type VI secretion system 1. Microbiology 160(Pt 9):1867-1873.
32. Castang S, McManus HR, Turner KH, Dove SL (2008) H-NS family members function coordinately in an opportunistic pathogen. Proc Natl Acad Sci USA 105(48):18947-18952.
33. Cuthbertson L, Nodwell JR (2013) The TetR family of regulators. Microbiol Mol Biol Rev 77(3):440-475.
34. Ishikawa T, Rompikuntal PK, Lindmark B, Milton DL, Wai SN (2009) Quorum sensing regulation of the two hcp alleles in Vibrio cholerae O1 strains. PLoS One 4(8):e6734.
35. Wright MS, et al. (2014) New insights into dissemination and variation of the health care-associated pathogen Acinetobacter baumannii from genomic analysis. MBio 5(1):e00963-13.
36. Andersson DI, Hughes D (2010) Antibiotic resistance and its cost: Is it possible to reverse resistance? Nat Rev Microbiol 8(4):260-271.
37. Sturm A, et al. (2011) The cost of virulence: Retarded growth of Salmonella Typhimurium cells expressing type III secretion system 1. PLoS Pathog 7(7):e1002143.
38. Eijkelkamp BA, et al. (2013) H-NS plays a role in expression of Acinetobacter baumannii virulence features. Infect Immun 81(7):2574-2583.
39. Hornsey M, et al. (2011) Whole-genome comparison of two Acinetobacter baumannii isolates from a single patient, where resistance developed during tigecycline therapy. J Antimicrob Chemother 66(7):1499-1503.
40. Bankevich A, et al. (2012) SPAdes: A new genome assembly algorithm and its applications to single-cell sequencing. J Comput Biol 19(5):455-477.
41. Norton MD, Spilkia AJ, Godoy VG (2013) Antibiotic resistance acquired through a DNA damage-inducible response in Acinetobacter baumannii. J Bacteriol 195(6):1335-1345.
42. Piechaud M, Second L (1951) [Studies of 26 strains of Moraxella Iwoffi]. Ann Inst Pasteur (Paris) 80(1):97-99.
43. Juni E (1972) Interspecies transformation of Acinetobacter: Genetic evidence for a ubiquitous genus. J Bacteriol 112(2):917-931.
44. MacIntyre DL, Miyata ST, Kitaoka M, Pukatzki S (2010) The Vibrio cholerae type VI secretion system displays antimicrobial properties. Proc Natl Acad Sci USA 107(45):19520-19524.
45. Bryksin AV, Matsumura I (2010) Rational design of a plasmid origin that replicates efficiently in both gram-positive and gram-negative bacteria. PLoS One 5(10):e13244.
46. Dykxhoorn DM, St Pierre R, Linn T (1996) A set of compatible tac promoter expression vectors. Gene 177(1-2):133-136.
47. Scott NE, et al. (2014) Diversity within the O-linked protein glycosylation systems of acinetobacter species. Mol Cell Proteomics 13(9):2354-2370.
48. Hunger M, Schmucker R, Kishan V, Hillen W (1990) Analysis and nucleotide sequence of an origin of DNA replication in Acinetobacter calcoaceticus and its use for Escherichia coli shuttle plasmids. Gene 87(1):45-51.